Koers Alternate Health Corp. Canadian Securities Exchange
Aandelen
AHG
CA02090B1022
Farmaceutische producten
Omzet 2017 | 13,25 mln. 9,74 mln. 9 mln. | Omzet 2018 | 577K 424K 392K | Marktkapitalisatie | 22,67 mln. 16,65 mln. 15,4 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -26 mln. -19,1 mln. -17,66 mln. | Nettowinst (verlies) 2018 | -24 mln. -17,63 mln. -16,3 mln. | EV/omzet 2017 | 6,25 x |
Nettoliquiditeiten 2017 | 893K 656K 606K | Nettoliquiditeiten 2018 | 773K 568K 525K | EV/omzet 2018 | 37,9 x |
K/w-verhouding 2017 |
-3,04
x | K/w-verhouding 2018 |
-0,76
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Howard Mann
FOU | Founder | - | 11-12-18 |
Director of Finance/CFO | - | 25-01-18 | |
Chairman | - | 05-04-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James E. Tykoliz
BRD | Director/Board Member | - | 16-04-15 |
Chairman | - | 05-04-17 | |
Howard Mann
FOU | Founder | - | 11-12-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,67% | 5,41 mld. | |
-35,93% | 3,52 mld. | |
-6,69% | 2,96 mld. | |
-27,73% | 2,6 mld. | |
-11,46% | 2,29 mld. | |
+38,57% | 1,89 mld. | |
+38,46% | 1,47 mld. | |
-16,41% | 1,43 mld. | |
+42,86% | 1,36 mld. |